Social stress is linked to lower bone density after menopause

Social stress is linked to lower bone density after menopause

(MENAFN – Jordan Study) Older women with high levels of social pressure may be more likely to develop fragile bones, outbreaks after menopause than their colleagues who have life-free worries, in a study t recently.

Researchers followed 11,020 post-menopausal women over six years, giving them periodic bone mineral density (BMD) tests and pine assessments. Participants rated their level of social pressure, or interactions or negative relationships; their social support, or their positive relationship; and social functioning, or restrictions on social activity.

Each one-point increase in social pressure scores related to a greater loss of 0.082 percent of BMD in the neck, 0.10 percent more BMD loss at the hip, while 0.069 percent of BMD in the lower spine, the study received, lost.

'Fractures are a major societal burden affecting one in two older people, due to a variety of risk factors that lead to bone loss; said Shawna Follis, principal author of the study and researcher at the University of Arizona in Tucson.

We found that high social stress is one risk factor that increases bone loss among women who are aging; Follis said by email.

Reduced estrogen production during menopause and later production of new bone tissue in women can slow down. Over time, this process reduces BMD and increases the risk of osteoporosis.

Bones are thinned by fragile osteoporosis and broken more easily.

Much of the previous research focused on links between osteoporosis and mental health on whether weakening due to bone thinning or fractures could increase mood disorders such as depression or anxiety, the researchers' note.

In the current study, published in the Journal of Epidemiology & Health Community, high levels of social stress were associated with lower BMD even after researchers accounted for other factors that can influence bone health such as age, education, problems. chronic health, weight, smoking status, alcohol use, hormonal therapy, age at menopause, physical activity, and broken history.

Lower social performance was associated with larger reductions in BMD in the neck and hip, and was found in the current study. And social support was low with more cuts in the neck.

The study does not prove that social stresses directly affect bone mineral density, and researchers did not look at the link between social stresses and falls or different fractures. And it is impossible to say from the study whether social stress mitigation would affect bone health.

However, the results suggest that older women with lower stress may have healthier bones and lower risk of fracture, says Dr JoAnn Pinkerton, director of the health of the midlands at Aughty University Health System. Newry in Charlottesville, Virginia and executive director of the North American Menopause Association.

'For women who are anxious or have higher levels of social stress, care, cognitive therapy, self-mitigation strategies, yoga, counseling, access to a community building, or, if necessary, medications of the levels t reduce psychosocial stress; Pinkerton, who had participated in the study, said an e-mail.

When women have osteoporosis, there are still things that can be done to prevent bones becoming brighter, and Pinkerton adds.

“Calcium, with vitamin D and strength training can prevent further bone loss,” Pinkerton said. While many women are afraid of the side effects associated with medications to treat osteoporosis, the side effects are rarely occurring and life may be changing. ;

Osteoporosis medication such as Fosamax (sodium alendronate), Actonel (sodium risedronate), and Boniva (sodium ibandronate) are working by easing how fast the old body puts out bone, allowing time to get back bone and minus probability.

These medicines can cause nausea and abdominal pain, as well as rare but more serious side effects such as cracks in the backbone or damage to the injured person. Alternative treatments include estrogen or two injected medicines, denosumab and teriparatide.

MENAFN1508201900280000ID1098885414

.

Leave a comment

Send a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.